• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

萝卜硫素通过miR-199a-5p/Sirt1/CD44ICD信号通路抑制皮肤鳞状细胞癌细胞增殖。

Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway.

作者信息

Zhang Yang, Ai Ping, Chen Shang-Zhou, Lei Shu-Ying

机构信息

Department of Dermatology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, PR China.

Department of Dermatology, Minda Hospital of Hubei Minzu University, Enshi, PR China.

出版信息

Immunopharmacol Immunotoxicol. 2023 Feb;45(1):52-60. doi: 10.1080/08923973.2022.2112221. Epub 2022 Aug 22.

DOI:10.1080/08923973.2022.2112221
PMID:35947042
Abstract

BACKGROUND

The present study aimed to explore the impact of sulforaphane on the growth of sSCC cells, and the activation of miR-199a-5pSirt1 and CD44ICD signaling pathways.

METHODS

Cell viability, count, apoptosis, and invasion assays were performed in the sSCC cell line (SCC-13) in which miR-199a-5p was over-expressed or under-expressed. The expression levels of miR-199a-5p, Sirt1 and CD44ICD mRNA were measured by quantitative real-time polymerase chain reaction (qRT-PCR).

RESULTS

Sulforaphane significantly inhibited the cell growth and invasion of SCC-13 cells, and dramatically induced cell apoptosis. Additionally, sulforaphane also greatly increased miR-199a-5p expression and suppressed Sirt1 and CD44ICD mRNA levels. Moreover, miR-199a-5p overexpression considerably down-regulated the expressions of Sirt1 and CD44ICD mRNA, and promoted the ability of sulforaphane to represses cell growth and invasion, and to induce cell apoptosis. However, miR-199a-5p underexpression has the opposite effects.

CONCLUSIONS

Sulforaphane appears to inhibit sCC progression by impacting its growth and invasion ability, and regulates miR-199a-5p/Sirt1 and CD44ICD signaling pathways, and may be utilized to develop a curative approach for sSCC.

摘要

背景

本研究旨在探讨萝卜硫素对皮肤鳞状细胞癌(sSCC)细胞生长以及miR-199a-5p/Sirt1和CD44ICD信号通路激活的影响。

方法

在miR-199a-5p过表达或低表达的sSCC细胞系(SCC-13)中进行细胞活力、计数、凋亡和侵袭实验。通过定量实时聚合酶链反应(qRT-PCR)检测miR-199a-5p、Sirt1和CD44ICD mRNA的表达水平。

结果

萝卜硫素显著抑制SCC-13细胞的生长和侵袭,并显著诱导细胞凋亡。此外,萝卜硫素还大幅增加miR-199a-5p的表达,并抑制Sirt1和CD44ICD mRNA水平。而且,miR-199a-5p过表达显著下调Sirt1和CD44ICD mRNA的表达,并增强萝卜硫素抑制细胞生长和侵袭以及诱导细胞凋亡的能力。然而,miR-199a-5p低表达则产生相反的效果。

结论

萝卜硫素似乎通过影响sSCC的生长和侵袭能力来抑制其进展,并调节miR-199a-5p/Sirt1和CD44ICD信号通路,可能可用于开发sSCC的治疗方法。

相似文献

1
Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway.萝卜硫素通过miR-199a-5p/Sirt1/CD44ICD信号通路抑制皮肤鳞状细胞癌细胞增殖。
Immunopharmacol Immunotoxicol. 2023 Feb;45(1):52-60. doi: 10.1080/08923973.2022.2112221. Epub 2022 Aug 22.
2
MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.miR-199a-5p 通过靶向 Sirt1 和 CD44ICD 切割信号抑制皮肤鳞状细胞癌干细胞的干性。
Cell Cycle. 2020 Jan;19(1):1-14. doi: 10.1080/15384101.2019.1689482. Epub 2019 Dec 6.
3
HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.HSC 来源的外泌体 miR-199a-5p 通过靶向 SIRT1 在肝纤维化中促进 HSC 活化和肝细胞 EMT。
Int Immunopharmacol. 2023 Nov;124(Pt B):111002. doi: 10.1016/j.intimp.2023.111002. Epub 2023 Oct 5.
4
Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade.靶向微小RNA-199a-5p通过SIRT1-p53级联反应预防毛果芸香碱诱导的癫痫持续状态和癫痫损伤。
Epilepsia. 2016 May;57(5):706-16. doi: 10.1111/epi.13348. Epub 2016 Mar 6.
5
MiR-199a-5p suppresses proliferation and invasion of human laryngeal cancer cells.miR-199a-5p 抑制人喉癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12200-12207. doi: 10.26355/eurrev_202012_24010.
6
Atherosclerosis-associated endothelial dysfunction is promoted by miR-199a-5p/SIRT1 axis regulated by circHIF1ɑ.由circHIF1ɑ调控的miR-199a-5p/SIRT1轴促进动脉粥样硬化相关的内皮功能障碍。
Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1619-1631. doi: 10.1016/j.numecd.2023.05.007. Epub 2023 May 11.
7
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.
8
Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma.微小RNA-199a-5p通过抑制滤泡性甲状腺癌中的结缔组织生长因子(CTGF)发挥肿瘤抑制作用。
Med Sci Monit. 2016 Apr 11;22:1210-7. doi: 10.12659/msm.895788.
9
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.人脐带间充质干细胞治疗通过 miR-199a-5p/Sirt1/p53 轴增加 CD4+T 细胞衰老改善狼疮。
Theranostics. 2021 Jan 1;11(2):893-905. doi: 10.7150/thno.48080. eCollection 2021.
10
microRNA-199a-5p mediates high glucose-induced reactive oxygen species production and apoptosis in INS-1 pancreatic β-cells by targeting SIRT1.微小RNA-199a-5p通过靶向沉默信息调节因子1(SIRT1)介导高糖诱导的INS-1胰腺β细胞活性氧生成和细胞凋亡。
Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):1091-1098.

引用本文的文献

1
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays.新型噻唑基 SIRT2 抑制剂作为抗癌剂的发现:分子建模、化学合成和生物测定。
Int J Mol Sci. 2024 Oct 15;25(20):11084. doi: 10.3390/ijms252011084.
2
Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived.植物源性天然小分子化合物萝卜硫素预防和治疗癌症的潜在机制。
Mol Med. 2024 Jun 21;30(1):94. doi: 10.1186/s10020-024-00842-7.
3
Unconventional Remedies for Squamous Cell Carcinoma: A Journey into Alternative Treatments.
非传统疗法治疗鳞状细胞癌:探索另类治疗方法。
Curr Pharm Biotechnol. 2024;25(16):2047-2059. doi: 10.2174/0113892010286715240119061108.